Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Carlsmed (CARL) EBIAT (2024 - 2025)

Carlsmed (CARL) has disclosed EBIAT for 2 consecutive years, with -$8.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIAT fell 82.48% year-over-year to -$8.6 million, compared with a TTM value of -$28.6 million through Dec 2025, changed N/A, and an annual FY2025 reading of -$29.6 million, down 22.17% over the prior year.
  • EBIAT was -$8.6 million for Q4 2025 at Carlsmed, down from -$8.5 million in the prior quarter.
  • Across five years, EBIAT topped out at -$4.7 million in Q4 2024 and bottomed at -$8.6 million in Q4 2025.